Pauwels Eric 4

What Happened

Eric Pauwels, Chief Business Officer of PTC Therapeutics (PTCT), disposed of 3,019 shares on February 18, 2026 at $69.36 per share, netting approximately $209,398. The sale was an automatic sell-to-cover to satisfy tax withholding obligations tied to RSU vesting, not an independent open-market trade intended as a bet on the stock.

Key Details

• Transaction date & price: 2026-02-18, 3,019 shares at $69.36 each; total proceeds ≈ $209,398.
• Type: Sale (S) — reported as open market/private sale; executed automatically as sell-to-cover.
• Reason (footnote): Shares were sold pursuant to an irrevocable sell-to-cover election to satisfy tax withholding for vesting of RSUs — 5,500 RSUs (from a 22,000 RSU grant dated Feb 15, 2024) and 1,150 RSUs (from a 2,300 RSU grant dated Feb 15, 2024).
• Filing: Report filed 2026-02-20 for a 2026-02-18 transaction — appears timely (filed within two business days).

Context

Sell-to-cover transactions are routine tax-withholding actions when restricted stock units vest; they generally do not signal a change in an insider’s view of the company. This was not an exercise of options or a gift; it was an automatic sale to cover taxes associated with vested RSUs.